An anaplastic lymphoma kinase (ALK) fusion oncogene positive metastatic sarcomatoid carcinoma of the lung with good response to crizotinib

AME Case Reports ◽

10.21037/acr.2018.01.01 ◽

2018 ◽

Vol 2 ◽

pp. 2-2 ◽

Author(s):

Ann Valter ◽

Retlav Roosipuu ◽

Hannes Tamm ◽

Peeter Padrik

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Sarcomatoid Carcinoma ◽

Anaplastic Lymphoma

Download Full-text

A Rare Case of Pulmonary Sarcomatoid Carcinoma Harboring the Gene Fusion of the Anaplastic Lymphoma Kinase With the Echinoderm Microtubule-Associated Protein-Like 4

CHEST Journal ◽

10.1378/chest.1992623 ◽

2014 ◽

Vol 146 (4) ◽

pp. 637A

Author(s):

Xiao Song ◽

Yang Yang ◽

Junjie Zhu ◽

Jianfang Xu

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Gene Fusion ◽

Rare Case ◽

Sarcomatoid Carcinoma ◽

Anaplastic Lymphoma ◽

Pulmonary Sarcomatoid Carcinoma

Download Full-text

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene

Lung Cancer ◽

10.1016/j.lungcan.2012.05.093 ◽

2012 ◽

Vol 77 (3) ◽

pp. 507-514 ◽

Author(s):

Giuseppe Pelosi ◽

Patrizia Gasparini ◽

Alberto Cavazza ◽

Giulio Rossi ◽

Paolo Graziano ◽

...

Keyword(s):

Molecular Characterization ◽

Anaplastic Lymphoma Kinase ◽

Sarcomatoid Carcinoma ◽

Anaplastic Lymphoma ◽

Pulmonary Sarcomatoid Carcinoma

Download Full-text

Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series

Head & Neck ◽

10.1002/hed.23884 ◽

2015 ◽

Vol 37 (5) ◽

pp. E66-E69 ◽

Author(s):

Sung Min Kim ◽

Moon Jin Kim ◽

Hyun Ae Jung ◽

Jong-Mu Sun ◽

Yoon-La Choi ◽

...

Keyword(s):

Head And Neck ◽

Treatment Effect ◽

Anaplastic Lymphoma Kinase ◽

Sarcomatoid Carcinoma ◽

Case Series ◽

Anaplastic Lymphoma

Download Full-text

Regulated expression of the Anaplastic Lymphoma Kinase (ALK) in cultured rat hepatic stellate cells during transdifferentiation into myofibroblasts

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-861584 ◽

2005 ◽

Vol 43 (01) ◽

Author(s):

M Antoine ◽

CG Tag ◽

W Wirz ◽

M Mavituna ◽

AM Gressner ◽

...

Keyword(s):

Hepatic Stellate Cells ◽

Anaplastic Lymphoma Kinase ◽

Stellate Cells ◽

Anaplastic Lymphoma ◽

Regulated Expression

Download Full-text

Anaplastic Lymphoma Kinase in Human Cancer

Critical Reviews™ in Oncogenesis ◽

10.1615/critrevoncog.v17.i2.10 ◽

2012 ◽

Vol 17 (2) ◽

pp. 123-143 ◽

Author(s):

Christina Schonherr ◽

Bengt Hallberg ◽

Ruth Palmer

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Human Cancer ◽

Anaplastic Lymphoma

Download Full-text

Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct04009317 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Line Treatment ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Anaplastic lymphoma kinase spares organ growth during nutrient restriction in Drosophila.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12593957.791402800 ◽

2012 ◽

Author(s):

Savraj Grewal

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Nutrient Restriction ◽

Organ Growth ◽

Anaplastic Lymphoma

Download Full-text

Faculty Opinions recommendation of The anaplastic lymphoma kinase in the pathogenesis of cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13353985.14725086 ◽

2011 ◽

Author(s):

Ruth Palmer

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Anaplastic Lymphoma

Download Full-text

Faculty Opinions recommendation of Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12934957.14822055 ◽

2012 ◽

Author(s):

John Proudfoot

Keyword(s):

Drug Design ◽

Anaplastic Lymphoma Kinase ◽

Dual Inhibitor ◽

Structure Based Drug Design ◽

Anaplastic Lymphoma ◽

Mesenchymal Epithelial Transition Factor ◽

Factor C ◽

Mesenchymal Epithelial Transition

Download Full-text

Faculty Opinions recommendation of Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12934957.14323054 ◽

2011 ◽

Author(s):

John Lowe

Keyword(s):

Drug Design ◽

Anaplastic Lymphoma Kinase ◽

Dual Inhibitor ◽

Structure Based Drug Design ◽

Anaplastic Lymphoma ◽

Mesenchymal Epithelial Transition Factor ◽

Factor C ◽

Mesenchymal Epithelial Transition

Download Full-text